Preface
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
ii-ii
Author(s):
Elke S. Bergmann-Leitner
A Prevention Strategy for Circumventing Drug Resistance in Cancer Chemotherapy
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1595-1614
Author(s):
Gerald D. Frenkel and Paula B. Caffrey
Rationally Designed Anti-mitotic Agents with Pro-Apoptotic Activity
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1627-1639
Author(s):
Fatih M. Uckun
Early Development of Cyclin Dependent Kinase Modulators
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1669-1687
Author(s):
K.K. Roy and E.A. Sausville
License to Kill Tumors: How Much Hope is Justified for Trail?
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1689-1701
Author(s):
S. Frank and A.D. Ebert
Identification of a Novel Human Peroxisomal 2,4-Dienoyl-CoA Reductase Related Protein Using the M13 Phage Protein VI Phage Display Technology
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
4
Page:
545-552
Author(s):
L. Amery, G. P. Mannaerts, S. Subramani, P. P. Van Veldhoven and M. Fransen
Substrate Phage as a Tool to Identify Novel Substrate Sequences of Proteases
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
4
Page:
573-583
Author(s):
Shuichi Ohkubo, Kazutaka Miyadera, Yoshikazu Sugimoto, Ken-ichi Matsuo, Konstanty Wierzba and Yuji Yamada
Gene Therapy to Overcome Drug Resistance in Cancer: Targeting Key Regulators of the Apoptotic Pathway
Journal:
Current Gene Therapy
Volume:
1
Page:
317-324
Author(s):
Alain Piche and Claudine Rancourt
T Lymphocytes as Targets of Gene Transfer with Moloney-Type Retroviral Vectors
Journal:
Current Gene Therapy
Volume:
1
Page:
325-337
Author(s):
F. A. Ayuk, A. R. Zander and B. Fehse
Chemoprotection and Selection by Chemotherapy of Multidrug Resistance-associated Protein-1 (MRP1) Transduced Cells
Journal:
Current Gene Therapy
Volume:
1
Page:
359-366
Author(s):
M. Symann and J. P. Machiels